Janus Henderson Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.8M | Buy |
2,263,960
+2,211,360
| +4,204% | +$31M | 0.02% | 478 |
|
|
2025
Q1 | $827K | Hold |
52,600
| – | – | ﹤0.01% | 1718 |
|
|
2024
Q4 | $732K | Hold |
52,600
| – | – | ﹤0.01% | 1838 |
|
|
2024
Q3 | $489K | Hold |
52,600
| – | – | ﹤0.01% | 2046 |
|
|
2024
Q2 | $489K | Buy |
+52,600
| New | +$489K | ﹤0.01% | 2000 |
|
|
2023
Q4 | – | Sell |
-22,724
| Closed | -$121K | – | 2552 |
|
|
2023
Q3 | $121K | Buy |
22,724
+9
| +0% | +$48 | ﹤0.01% | 2487 |
|
|
2023
Q2 | $217K | Sell |
22,715
-46
| -0.2% | -$439 | ﹤0.01% | 2412 |
|
|
2023
Q1 | $251K | Buy |
+22,761
| New | +$251K | ﹤0.01% | 2375 |
|